vision loss with tirzepatide risks in patients using popular GLP-1 medications raise concerns Ozempic, Wegovy & Mounjaro Vision

Diana Harshbarger, a GOP representative and pharmacist, asked RFK Jr

Heart failure was reported in 24% of patients

Indications and Usage Saxenda (liraglutide) injection 3 mg is indicated in combination with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with body weight greater than 60kg and obesity Adults with overweight in the presence of at least one weight related comorbid condition Limitations of Use Saxenda contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist The safety and effectiveness of Saxenda in pediatric patients with type 2 diabetes have not been established Important Safety Information for Wegovy WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures

Proven Track Record in Drug Injury & MDL Cases Our attorneys have litigated complex product liability and pharmaceutical matters for years

Lee: There is growing interest in how GLP-1 medications may influence the brains reward system, particularly dopamine signaling